Jill Clendening
-
October 17, 2023
Tirzepatide trial shows additional 21.1% weight loss following intensive lifestyle intervention
A Vanderbilt clinical trial evaluating the injectable prescription medication tirzepatide, showed an additional 21.1% weight loss after intensive lifestyle intervention in adults with obesity or who were overweight with weight-related comorbidities, excluding Type 2 diabetes. -
October 12, 2023
Stevenson named chair of Department of Health Policy
David Stevenson has been named chair of the Department of Health Policy at Vanderbilt University Medical Center. -
September 28, 2023
Drug trial shows reduced abnormal bone formation in those with fibrodysplasia ossificans progressiva
A Vanderbilt clinical trial evaluating the investigational drug garetosmab has shown that it reduced soft-tissue flare-ups significantly and prevented new areas of abnormal bone formation in patients with fibrodysplasia ossificans progressiva. -
September 27, 2023
New SMART rotation of military personnel takes place
The latest Strategic Medical Asset Readiness Training (SMART) rotation, which included 12 members of the United States military, recently came to Vanderbilt University Medical Center to work in clinical areas of the adult hospital. -
September 22, 2023
Laboratory employees get an early look at new facility
Vanderbilt University Medical Center laboratory employees, their families and many others involved in the ongoing transformation of the Medical Center's laboratories had a first peek at the new 110,000-square-foot core laboratory space during a recent open house. -
September 20, 2023
Surgeons to lead multisite study of procedure to limit blood loss by partially blocking aorta
Vanderbilt care surgeons are leading a two-year, multicenter observational study of a minimally invasive technique to control life-threatening blood loss by inserting a balloon inside the aorta to restrict blood flow below the heart.